Pfizer to remain aggressive on obesity market after setback
By Michael Erman NEW YORK (Reuters) -Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile ...
Stay updated with breaking news from Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Michael Erman NEW YORK (Reuters) -Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile ...
Monday, at the JP Morgan Healthcare Conference, Pfizer Inc PFE CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning…
After a difficult first week of 2024, stock market indices are trying to bounce back. Investors have found renewed confidence that rate cuts are coming fast, and artificial intelligence is back to... -January 09, 2024 at 09:18 am EST - MarketScreener
Putting a difficult year in the rearview or shedding an older image were common talking points among biopharma CEOs.
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to...